Covid-19 vaccine: Time to test Covishield-Covaxin mix for immune response against D variant
Perhaps it is time for our scientists to test whether a mix of Covishield and Covaxin will increase the chances of a more effective immune response against the D variant
Reading Vaccine Findings Right: Covid vaccines get a reality check
Both the UK and the double-mutant variants seem to be subdued by the AstraZeneca and Pfizer vaccines, but the hardier double-mutant is less responsive
Combination numbers to open Covid lockdown
The growth rate of weekly average of the number of positive cases, Covid diagnosed/suspected deaths and hospital admissions need to inform unlock decisions
Patents must not impede pandemic response
Patents restrict access to essential technologies and constrict the ability of many countries to provide early and affordable services needed for an effective and equitable response
Covid-19: Fight the war, don’t battle waves
We must not let ourselves get trapped in a see-saw of lockdowns and laxity. Need to ensure testing, tracing and masking/distancing
Vaccine efficacy claims have confidence limits
It is necessary to report the 95% confidence intervals around both the overall vaccine trial result and for the values being reported for any subgroup of interest
Budget 2021: A broader head for healthcare
Union Budget 2021 India: Laboratory capacity will be expanded and One Health surveillance connectivity will be established across wildlife, veterinary and human populations.
Budget 2021 expectations: Budget must provide a booster shot for health
Union Budget 2021 Expectations for health sector: Increased spending on primary care will reflect the twin priorities of an effective pandemic response and building a stronger health system for the long term
Covid-19: Will the promise of vaccines match the promos?
‘Science by press release’ may be good for value of developers’ stocks, but regulatory approvals & public-health use require rigorously gathered, honestly reported data
When must politicians listen to scientists?
The purpose of scientific research in public health is to provide evidence-informed, context-relevant, resource optimising, culturally compatible and equity promoting recommendations
Depending on big hospitals to provide most of Post-Covid care is setting ourselves up for failure
Depending on big hospitals to provide most of Post-COvid care is setting ourselves up for failure. Community-based facilities, in or near PHcs, would be more accessible
Covid-19 outbreak and the RAT rage
The Year of the Rat is now seeing a rise in rapid antigen testing (RAT) for Covid-19.
Covid-19 bowls a re-infection googly
We have to maintain vigilance against the first bout of Covid-19 infection and draw assurance from the fact that our immune system cAn deal with reinfections
Covid vaccine race: Unfazed claims on ‘un-phased’ trials?
Commercial interests too play a very strong role since there is much money to be made for the industry, though the foundational science is public-funded.
Covid-19: Making sense of the sero-survey
The true prevalence rates are most likely to be lower than the rates reported, because of the inflation of false positives on mass screening.
Why using Covid-19 antigen test sensibly is important
With a multiplicity of tests, a problem will arise with the reporting and interpretation of total testing numbers.
Comparing countries on Covid-19 deaths
We need a slew of public health measures to contain Covid-19 and keep the total deaths in our population low even as the count of cases rises
Coronavirus pandemic: Covid, critics and contradictions
India should move ahead with the undeterred resolve of adopting context-defined and regionally-differentiated strategies, undistracted by critics
Clues to crack the COVID-19 puzzle
However, these measures tell us how well a test behaves in a group of persons, not particularly about the individual being tested.
Reading the Covid-19 numbers right
Talking about doubling-time between given periods without taking into account whether the underlying testing/case identification factors are comparable or not, or comparing case fatality ratios of countries without age-standa
Budget 2020: Health moves to private fast track
Budget 2020-21: Just as Anganwadi workers will be equipped with smartphones, frontline health workers too must be technology enabled to make primary healthcare more accessible, efficient and less doctor dependant
Guiding nutrition through thick and thin
Those who studied ‘undernutrition’ saw underweight, wasted or stunted children, or thin and anaemic adults as deficient in calories and essential nutrients.
Sound law: Defining a right to health
Madhya Pradesh will focus on access to clean water, nutrition, & other factors impacting health, apart from access to healthcare. Other states should emulate it
Ailing healthcare system needs more healing hands
The fault lines of the Indian healthcare system, especially those of our understaffed and under-skilled health workforce, are in urgent need of repair
Falling maternal mortality: Mothered by primary care & public financing
Two messages come through from the Indian experience: First, strong primary health care is essential to achieve the maximum impact. Second, public financing is vital for infrastructure development, health workforce skilling,
India needs to have multi-level response
Effective risk communication to the public is vital, to enable it to adopt preventive personal protection measures, seek timely medical care, and avoid mass panic
National Health Protection Scheme: Why insurance can’t replace primary healthcare
What’s in a name?”, asked a plaintive Romeo Montague, as he sought to woo Juliet of the Capulets. That question could be repeated as the Rashtriya Swasthya Bima Yojana (RSBY) changed name to the National Health Protection
Advertisement
Most Read
- Covid-19 Vaccine Certificate: Here’s how to download it from CoWin portal, Aarogya Setu app
- More Indian Railways' Special Trains to resume; see train list & their restoration dates
- Analyst Corner | HCL Tech: Maintain ‘hold’ with SOTP of Rs 150
- New Income Tax e-filing portal: ITR e-filing 2.0 portal link, features, benefits - all details here
- 10 stocks to buy now that could make you rich
- 'Make in India' boost! Indian Railways exports another 3000 HP locomotive to Mozambique
- Analyst Corner: Maintain ‘buy’ on SBI with target price of Rs 530
- Rakesh Jhunjhunwala-owned stock gains 20% in just 1 day; up 60% since April
- Four IPOs to hit markets next week; companies eye Rs 9,123 crore
- Rs 10,000/month Mutual Fund SIP for 20 years may return upto Rs 1 crore. Here's what investors need to know
Advertisement
Top News
- Market LIVE: Sensex trims opening losses, still in red, Nifty above 15,700; HDFC Bank, ICICI Bank, SBI drag
- Public Provident Fund: How to get Rs 1 crore with PPF
- One step closer to American dream! Visas open for Indian students who have applied in US Universities
- Corona LIVE: India logs 70,421 new Covid-19 cases, lowest since March 31; Active cases drop below 10 lakh
- Gold, silver under pressure as dollar strengthens; expect bullion prices to trade sideways this week
- Nifty set to touch 16,100, Bank Nifty may hit 36,200 in June 2021; TCS, SBI strong on charts
- DHFL shares stop trading on NSE, BSE; existing stock worth zero now
- Petrol and diesel price today 14 June 2021: Rates breach record highs; Check prices in Delhi, Mumbai here
- World Blood Donor Day 2021: Why there is a dip in blood donation due to covid -19
- Nifty to trade in 16200-15600 range this week, Bank Nifty remains in uptrend; Infosys, Tata Steel in focus
Advertisement
